Artedrone, a Truffle Capital’s medtech portfolio company developing an autonomous micro robotic platform to perform and democratize mechanical thrombectomy procedures to treat patients suffering from a stroke, announces preclinical studies show its Sasha microbotic system can autonomously perform mechanical thrombectomy for stroke treatment.